Nagasuma Chandra

At IISc, she has set up a systems biology and computational biochemistry laboratory, popularly known as Chandralab,[4] and hosts several research scholars.

[5] She also serves as a faculty at the National Network for Mathematical and Computational Biology, an educational agency funded by the Science and Engineering Research Board of the Government of India.

[6] Chandra's research focus is in the fields of computational systems biology, cell modeling and structural bioinformatics[3] and she leads a team of scientists who are involved in research in areas such as systems biology, computational immunology, structural bioinformatics and drug discovery.

[4] She has carried out studies on Mycobacterium tuberculosis, the causative pathogen of tuberculosis, with special emphasis on their metabolic processes and, along with M. Vijayan and K. Sekar, two of her colleagues at IISc,[7] has developed system models which has helped identify new drug targets against the disease.

[8] In 2017, the team led by her identified three drugs namely Ebselen, Vancomycin and Phenylarsine oxide that could be used in combination with Isoniazid, the principal antibiotic used against tuberculosis, to treat the drug-resistant strains of the pathogen.